Navigation Links
Talecris Biotherapeutics CEO Accepts 2010 Ernst & Young Entrepreneur Of The Year Award on Behalf of Employees and Patients
Date:6/18/2010

RESEARCH TRIANGLE PARK, N.C., June 18 /PRNewswire-FirstCall/ -- Lawrence D. Stern, chairman and CEO of Talecris Biotherapeutics (Nasdaq: TLCR), received the Ernst & Young Entrepreneur Of The Year® 2010 Award in the health sciences category in the Carolinas at a ceremony last night in Charlotte, N.C. The Ernst & Young awards program recognizes entrepreneurs who demonstrate extraordinary success in the areas of innovation, financial performance and personal commitment to their businesses.

Stern was one of ten CEOs selected as a winner from among 27 finalists by a panel of independent judges composed of prominent business leaders in North Carolina.

"I am honored to accept this award on behalf of Talecris employees and the patients whose lives are saved and enhanced by the critical-care therapies we discover and produce," said Stern. "This award represents not only my own entrepreneurial vision for the company, but the immense talent, spirit and drive of the Talecris employees who have translated our vision into a reality."  

Stern led the formation of Talecris in 2005 upon acquiring the assets of a division of Bayer Corporation. From these assets, the Talecris leadership team built new systems and processes to sustain the company's long-term growth and success as a global leader in developing, manufacturing and marketing protein therapies derived from human plasma. In five years' time, the company doubled its revenue, tripled the number of employees, launched new products and expanded its global presence. In 2009, Talecris achieved record sales of $1.53 billion.

About Talecris Biotherapeutics: Inspiration. Dedication. Innovation.

Talecris Biotherapeutics is a global biotherapeutic and biotechnology company that discovers, develops and produces critical care treatments for people with life-threatening disorders in a variety of therapeutic areas including immunology, pulmonology, neurology and hemostasis. For more information, please visit: www.talecris.com

About Ernst & Young's Entrepreneur Of The Year(R) Awards Program

Ernst & Young's Entrepreneur Of The Year® is the world's most prestigious business award for entrepreneurs. The award recognizes the contribution of individuals who inspire others through their vision, leadership and achievement. As the first and only global award of its kind, Ernst & Young Entrepreneur Of The Year® celebrates those who are building and leading successful, growing and dynamic businesses, recognizing them through regional, national and global awards programs in more than 135 cities in 50 countries.


'/>"/>
SOURCE Talecris Biotherapeutics
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Talecris Biotherapeutics Receives FDA Approval for PROLASTIN(R)-C
2. Talecris Forms Partnership to Co-Promote Life-Saving Rabies Products
3. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
4. Northwest Biotherapeutics Conducting Ovarian Cancer Clinical Trial With DCVax(R)-L at University of Pennsylvania
5. Juvaris BioTherapeutics Announces Cooperative Research and Development Agreement With The Centers for Disease Control and Prevention
6. Protalix BioTherapeutics Extends Research Agreement With Yissum Based on Promising Acetylcholinesterase Program Results in Animal Study
7. Oxygen Biotherapeutics, Inc. Receives Letter From FDA Outlining Path Forward to Resume Oxycyte Clinical Trials in TBI in U.S.A.
8. Oxford BioTherapeutics and GlaxoSmithKline Form Strategic Alliance to Develop Novel Cancer Therapeutic Antibodies
9. Oxygen Biotherapeutics, Inc. Submits Milestone Achievement Notice to Vatea Fund
10. Oxygen Biotherapeutics, Inc. Receives Phase II Trial Approval in Israel
11. Oxygen Biotherapeutics, Inc. to Webcast Shareholder Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/15/2017)... announced today that its fully owned USA -operating ... City Office in Yonkers, New York to ... 2 ) homecare therapy. This new East Coast location has also ... the company,s DMEPOS accreditation for Home/Durable Medical Equipment Services. ... Advanced Oxygen Therapy Inc. New York ...
(Date:8/11/2017)... , Aug. 11, 2017 DarioHealth Corp. (NASDAQ: ... health and big data solutions, today announced that it ... August 14 and host a conference call at 9:00am ... operating and financial results and its strategy and outlook ... hosted by Erez Raphael , Chief Executive Officer, ...
(Date:8/8/2017)... Aug. 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a ... reports its financial results for the second quarter ended ... the second quarter 2017 and to date: ... development programs for the Company,s lead project, BL-8040: ... study with BL-8040 as novel stem cell mobilization treatment ...
Breaking Medicine Technology:
(Date:8/16/2017)... ... August 16, 2017 , ... LabRoots , the leading provider ... the world, is excited to announce Andrew Ly as the winner of the LabRoots ... textbook costs. , Ly, who is in his third year at the University ...
(Date:8/16/2017)... (PRWEB) , ... August 16, 2017 , ... Fusion Flix ... premium original programming over four countries and millions of viewers in a partnership with ... rent or buy On-Demand and fully available on Blu Ray disc in 2018. Proceeds ...
(Date:8/16/2017)... ... 2017 , ... Kaviva , a health engagement technology ... market, with Los Angeles-based AIDS Healthcare Foundation ( AHF ), to provide their ... for nearly 800,000 individuals worldwide and is the largest HIV/AIDS organization in the ...
(Date:8/16/2017)... ... August 16, 2017 , ... ... and marketers of high-quality anti-aging skincare solutions, recently announced the launch of two ... are an affordable, yet effective alternative to expensive plastic surgery or in-patient cosmetic ...
(Date:8/16/2017)... (PRWEB) , ... August 16, 2017 , ... “Mom, God's Got This: Jamie's Story” is ... in love with the Lord and has an insatiable appetite for God’s Word. , “I ... those shelves, free gifts retrieved from packages of oatmeal. I have one to this day ...
Breaking Medicine News(10 mins):